Market Segmentation
- U.S. Cell & Gene Therapy Manufacturing, Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
- Cell therapy manufacturing
- Stem cell therapy
- Non stem cell therapy
- Gene therapy manufacturing
- Cell therapy manufacturing
- U.S. Cell & Gene Therapy Manufacturing, Scale Outlook (Revenue, USD Million; 2018 - 2030)
- Pre-commercial/R&D scale manufacturing
- Commercial scale manufacturing
- U.S. Cell & Gene Therapy Manufacturing, Mode Outlook (Revenue, USD Million, 2018 - 2030)
- Contract manufacturing
- In-house manufacturing
- U.S. Cell & Gene Therapy Manufacturing, Workflow Outlook (Revenue, USD Million; 2018 - 2030)
- Cell processing
- Cell banking
- Process development
- Fill & finish operations
- Analytical and quality testing
- Raw material testing
- Vector production
- Others
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Country market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Country market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
